Next Quarterly Earnings
Thursday, July 30, 2026
CW 31
After-Hours
In 25 days
SIGA Technologies
SIGA Technologies, a US-based biotechnology company, develops and markets innovative antiviral drugs for smallpox and other biothreats. Their leading product, TPOXX, is a critical public health therapy. SIGA is dedicated to protecting against severe infectious diseases.
All Dates
Earnings history data not available
Company Information
Name
SIGA Technologies
Country
🇺🇸
More Financial Information